13 results
PRE 14A
GLYC
GlycoMimetics Inc
22 Mar 24
Preliminary proxy
5:00pm
and global head for Ribociclib, accountable for worldwide launch preparations. During his tenure at Novartis, Mr. Semerjian worked on numerous launches … Committee reviews these directors’ overall service to the Company during their tenure as a director, including the number of meetings attended, level
8-K
EX-99.2
GLYC
GlycoMimetics Inc
5 Aug 21
Glycomimetics Reports Highlights and Financial Results
8:01am
in AML. During his 16-year tenure at Novartis, Mr. Semerjian held both strategic and operational leadership roles including US Hematology franchise head
8-K
97l gj5ilpnv
5 Aug 21
Glycomimetics Reports Highlights and Financial Results
8:01am
8-K
EX-10.1
5om1mgab 45sv
28 Jul 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.2
ctqx0pw4m6 0syo5ls9t
4 Apr 14
GlycoMimetics Reports Fourth Quarter and Year-End 2013 Results
12:00am
8-K
EX-3.2
hxv7wfe ob3l5h4dd1
15 Jan 14
Amendments to Articles of Incorporation or Bylaws
12:00am
S-1
EX-3.5
vuxcovg t8i
4 Oct 13
IPO registration
12:00am
- Prev
- 1
- Next